Clinical Trial Update: Phase II Study of Irinotecan and Cisplatin in Extensive-stage Small Cell Lung Cancer [Phase 2]

View source ↗

Summary

This update notes the completion of a Phase II trial evaluating irinotecan in combination with cisplatin for extensive-stage small cell lung cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Extensive-stage Small Cell Lung Cancer

Drugs mentioned

• CISPLATIN (cisplatin)
• Irinotecan (Irinotecan)

Snippet

Sponsor: Chinese Academy of Medical Sciences | Conditions: Extensive-stage Small Cell Lung Cancer | Phase 2 | Status: COMPLETED